Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Marshall Stoller, MD (ucsf)
Headshot of Marshall Stoller
Marshall Stoller

Description

Summary

Details

Keywords

Cystinuria, Dapagliflozin, Study Drug

Eligibility

Location

  • University of California, San Francisco
    San Francisco California 94143 United States

Lead Scientist at University of California Health

  • Marshall Stoller, MD (ucsf)
    My clinical and research efforts continue to be centered around the treatment and understanding the pathogenesis of urinary stone disease. I have recently identified zinc as a critical factor in the early mineralization process.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05058859
Phase
Phase 2 Cystinuria Research Study
Study Type
Interventional
Participants
Expecting 10 study participants
Last Updated